SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2018 / Cilt: 48 - Sayı: 1

Cross-cultural adaptation, reliability, and validity of the Turkish version of the Cancer Fatigue Scale in patients with breast cancer

Mine UYANIK
Orkun Tahir ARAN
Sedef ŞAHİN
Meral HURİ
Pages
124–130
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The CFS may be used to evaluate the severity of fatigue in Turkish-speaking breast cancer patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The Cancer Fatigue Scale (CFS) was developed to evaluate the severity of fatigue in patients with breast cancer.
📊
Key Findings & Data:Theaim of this study is to translate and culturally adapt a Turkish version and investigate the validity and reliability of the CFS in Turkishpatients with fatigue symptoms.Materials and methods: Eighty participants completed the Turkish version of the CFS for breast cancer and the European Organizationfor Research and Treatment of Cancer Quality of Life Core Questionnaire “Core 30” (EORTC QLQ-C30).
💡
Conclusion & Impact:The CFS may be used to evaluate the severity of fatigue in Turkish-speaking breast cancer patients.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: The Cancer Fatigue Scale (CFS) was developed to evaluate the severity of fatigue in patients with breast cancer. Theaim of this study is to translate and culturally adapt a Turkish version and investigate the validity and reliability of the CFS in Turkishpatients with fatigue symptoms.Materials and methods: Eighty participants completed the Turkish version of the CFS for breast cancer and the European Organizationfor Research and Treatment of Cancer Quality of Life Core Questionnaire “Core 30” (EORTC QLQ-C30). Test–retest reliability wasevaluated by repeating the CFS with a 7-day interval.Results: The CFS demonstrated high test–retest reliability (ICC = 0.95) and good internal consistency (Cronbach’s alpha = 0.74) for alldomains. The Kaiser–Meyer–Olkin measure of sampling adequacy was found to be 0.819, which is considered to be satisfactory (>0.5).Correlations between domains of CFS physical and EORTC physical (r: 0.77), CFS cognitive and EORTC cognitive (r: 0.70), and CFSphysical and EORTC fatigue (r: 0.80) were found to be significant.Conclusion: The Turkish version of the CFS is a reliable and valid instrument to assess physical, effective, and cognitive dimensions offatigue. The CFS may be used to evaluate the severity of fatigue in Turkish-speaking breast cancer patients.

🔖

Cite This Article

UYANIK, M., ARAN, O. T., ŞAHİN, S., HURİ, M. (2022). Cross-cultural adaptation, reliability, and validity of the Turkish version of the Cancer Fatigue Scale in patients with breast cancer. Turkish Journal of Medical Sciences, Cilt: 48 - Sayı: 1, 124–130. https://ajindex.com/articles/610361

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Cancer-Related Fatigue and Anemia. Version I. Fort Washington, PA, USA: NCCN; 2014.
  2. Minton O, Stone P. How common is fatigue in diseasefree breast cancer survivors? A systematic review of the literature. Breast Cancer Res Tr 2008; 112: 5-13.
  3. Ganz PA, Bower JE. Cancer related fatigue: a focus on breast cancer and Hodgkin’s disease survivors. Acta Oncol 2007; 46: 474-479.
  4. Goedendorp MM, Gielissen MFM, Verhagen CAH, Peters MEJW, Bleijenberg G. Severe fatigue and related factors in cancer patients before the initiation of treatment. Brit J Cancer 2008; 99: 1408-1414.
  5. Abrahams HJ G, Gielissen MFM, Schmits IC, Verhagen CAHHVM, Rovers MM, Knoop H. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors. Ann Oncol 2016; 27: 965-974.
  6. Prue G, Rankin J, Allen J, Gracey J, Cramp F. Cancer-related fatigue: a critical appraisal. Eur J Cancer 2006; 42: 846-863.
  7. Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA, Ogaily MS. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol 2014; 32: 1840-1850. Schneider RA. Reliability and validity of the Multidimensional Fatigue Inventory (MFI-20) and the Rhoten Fatigue Scale among rural cancer outpatients. Cancer Nurs 1998; 21: 370- 373. Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum 1998; 25: 677-684.
  8. Smets EMA, Garssen B, Bonke BD, De Haes JCJM. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychiat Res 1995; 39: 315-325.
  9. Okuyama T, Akechi T, Kugaya A, Okamura H, Shima Y, Maruguchi M, Uchitomi Y. Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manag 2000; 19: 5-14.
  10. Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T, Uchitomi Y. Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer 2000; 8: 215-222.
  11. Ünsal D, Aksu A, Bağrıaçık Ü, Akmansu M. Postmastektomi radyoterapi uygulanan meme kanserli olgularda gelişen yorgunluğun derecesi, serum sitokin ve leptin düzeyle